Matsuyama Red Cross Hospital /ID# 278660

Matsuyama, Ehime 790-8524

1 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant — Recruiting now